mhld-20240930FALSE2024Q3000141210012-31http://www.maiden.bm/20240930#NotesReceivableRelatedPartyMemberhttp://www.maiden.bm/20240930#NotesReceivableRelatedPartyMemberhttp://www.maiden.bm/20240930#AlternativeInvestmentMemberhttp://www.maiden.bm/20240930#AlternativeInvestmentMemberhttp://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilitieshttp://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilitieshttp://fasb.org/us-gaap/2024#OtherAssetshttp://fasb.org/us-gaap/2024#OtherAssetsxbrli:sharesiso4217:USDxbrli:sharesiso4217:USDmhld:segmentmhld:securityxbrli:puremhld:unitmhld:perUnitiso4217:EUR00014121002024-01-012024-09-3000014121002024-11-0700014121002024-09-3000014121002023-12-310001412100srt:AffiliatedEntityMember2024-09-300001412100srt:AffiliatedEntityMember2023-12-3100014121002023-01-012023-12-310001412100srt:AffiliatedEntityMember2024-01-012024-09-300001412100srt:AffiliatedEntityMember2023-01-012023-12-3100014121002024-07-012024-09-3000014121002023-07-012023-09-3000014121002023-01-012023-09-300001412100us-gaap:CommonStockMember2024-06-300001412100us-gaap:CommonStockMember2023-06-300001412100us-gaap:CommonStockMember2023-12-310001412100us-gaap:CommonStockMember2022-12-310001412100us-gaap:CommonStockMember2024-01-012024-09-300001412100us-gaap:CommonStockMember2023-01-012023-09-300001412100us-gaap:CommonStockMember2024-09-300001412100us-gaap:CommonStockMember2023-09-300001412100us-gaap:AdditionalPaidInCapitalMember2024-06-300001412100us-gaap:AdditionalPaidInCapitalMember2023-06-300001412100us-gaap:AdditionalPaidInCapitalMember2023-12-310001412100us-gaap:AdditionalPaidInCapitalMember2022-12-310001412100us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001412100us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001412100us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001412100us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001412100us-gaap:AdditionalPaidInCapitalMember2024-09-300001412100us-gaap:AdditionalPaidInCapitalMember2023-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001412100us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001412100us-gaap:RetainedEarningsMember2024-06-300001412100us-gaap:RetainedEarningsMember2023-06-300001412100us-gaap:RetainedEarningsMember2023-12-310001412100us-gaap:RetainedEarningsMember2022-12-310001412100srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2023-09-300001412100us-gaap:RetainedEarningsMember2024-07-012024-09-300001412100us-gaap:RetainedEarningsMember2023-07-012023-09-300001412100us-gaap:RetainedEarningsMember2024-01-012024-09-300001412100us-gaap:RetainedEarningsMember2023-01-012023-09-300001412100us-gaap:RetainedEarningsMember2024-09-300001412100us-gaap:RetainedEarningsMember2023-09-300001412100us-gaap:TreasuryStockCommonMember2024-06-300001412100us-gaap:TreasuryStockCommonMember2023-06-300001412100us-gaap:TreasuryStockCommonMember2023-12-310001412100us-gaap:TreasuryStockCommonMember2022-12-310001412100us-gaap:TreasuryStockCommonMember2024-07-012024-09-300001412100us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001412100us-gaap:TreasuryStockCommonMember2024-01-012024-09-300001412100us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001412100us-gaap:TreasuryStockCommonMember2024-09-300001412100us-gaap:TreasuryStockCommonMember2023-09-3000014121002023-09-3000014121002022-12-310001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2024-09-300001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2024-09-300001412100us-gaap:OperatingSegmentsMember2024-09-300001412100us-gaap:CorporateNonSegmentMembermhld:DiversifiedReinsuranceSegmentMember2024-09-300001412100us-gaap:CorporateNonSegmentMembermhld:AmTrustReinsuranceSegmentMember2024-09-300001412100us-gaap:CorporateNonSegmentMember2024-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2024-09-300001412100mhld:AmTrustReinsuranceSegmentMember2024-09-300001412100us-gaap:OperatingSegmentsMembermhld:DiversifiedReinsuranceSegmentMember2023-12-310001412100us-gaap:OperatingSegmentsMembermhld:AmTrustReinsuranceSegmentMember2023-12-310001412100us-gaap:OperatingSegmentsMember2023-12-310001412100us-gaap:CorporateNonSegmentMembermhld:DiversifiedReinsuranceSegmentMember2023-12-310001412100us-gaap:CorporateNonSegmentMembermhld:AmTrustReinsuranceSegmentMember2023-12-310001412100us-gaap:CorporateNonSegmentMember2023-12-310001412100mhld:DiversifiedReinsuranceSegmentMember2023-12-310001412100mhld:AmTrustReinsuranceSegmentMember2023-12-310001412100us-gaap:OperatingSegmentsMembermhld:InternationalInsuranceMembermhld:DiversifiedReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:InternationalInsuranceMembermhld:DiversifiedReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SmallCommercialBusinessMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SmallCommercialBusinessMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyProgramMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyProgramMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyRiskAndExtendedWarrantyMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyRiskAndExtendedWarrantyMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:InternationalInsuranceMembermhld:DiversifiedReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:InternationalInsuranceMembermhld:DiversifiedReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SmallCommercialBusinessMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SmallCommercialBusinessMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyProgramMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyProgramMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyRiskAndExtendedWarrantyMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100us-gaap:OperatingSegmentsMembermhld:SpecialtyRiskAndExtendedWarrantyMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100us-gaap:USTreasuryBondSecuritiesMember2024-09-300001412100us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2024-09-300001412100us-gaap:ForeignGovernmentDebtMember2024-09-300001412100us-gaap:CollateralizedLoanObligationsMember2024-09-300001412100us-gaap:CorporateBondSecuritiesMember2024-09-300001412100us-gaap:USTreasuryBondSecuritiesMember2023-12-310001412100us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001412100us-gaap:ForeignGovernmentDebtMember2023-12-310001412100us-gaap:CollateralizedLoanObligationsMember2023-12-310001412100us-gaap:CorporateBondSecuritiesMember2023-12-310001412100us-gaap:USTreasurySecuritiesMember2024-09-300001412100us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-300001412100srt:StandardPoorsAAARatingMember2024-09-300001412100mhld:StandardPoorsAaPlusAaAaMinusRatingMember2024-09-300001412100mhld:StandardPoorsSingleaPlusSingleaAndSingleaMinusMember2024-09-300001412100mhld:StandardPoorsBbbPlusBbbBbbMinusRatingMember2024-09-300001412100us-gaap:USTreasurySecuritiesMember2023-12-310001412100us-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-12-310001412100srt:StandardPoorsAAARatingMember2023-12-310001412100mhld:StandardPoorsAaPlusAaAaMinusRatingMember2023-12-310001412100mhld:StandardPoorsSingleaPlusSingleaAndSingleaMinusMember2023-12-310001412100mhld:StandardPoorsBbbPlusBbbBbbMinusRatingMember2023-12-310001412100mhld:StandardPoorsBbPlusOrLowerRatingMember2023-12-310001412100us-gaap:PrivateEquityFundsMember2024-09-300001412100us-gaap:PrivateEquityFundsMember2023-12-310001412100mhld:PrivateCreditLendingMember2024-09-300001412100mhld:PrivateCreditLendingMember2023-12-310001412100mhld:OtherPrivatelyHeldInvestmentsMember2024-09-300001412100mhld:OtherPrivatelyHeldInvestmentsMember2023-12-310001412100mhld:DirectLendingEntitiesMember2024-09-300001412100mhld:DirectLendingEntitiesMember2023-12-310001412100mhld:PrivatelyHeldEquitySecuritiesInCommonStockMember2024-09-300001412100mhld:PrivatelyHeldEquitySecuritiesInCommonStockMember2023-12-310001412100mhld:PrivatelyHeldEquityInvestmentsInPreferredStockMember2024-09-300001412100mhld:PrivatelyHeldEquityInvestmentsInPreferredStockMember2023-12-310001412100mhld:PubliclyTradedEquityInvestmentsMember2024-09-300001412100mhld:PubliclyTradedEquityInvestmentsMember2023-12-310001412100us-gaap:CommonStockMember2024-09-300001412100us-gaap:PreferredStockMember2024-09-300001412100us-gaap:RealEstateInvestmentMember2024-09-300001412100us-gaap:RealEstateInvestmentMember2023-12-310001412100us-gaap:OtherInvestmentsMember2024-09-300001412100us-gaap:OtherInvestmentsMember2023-12-310001412100us-gaap:FixedIncomeSecuritiesMember2024-07-012024-09-300001412100us-gaap:FixedIncomeSecuritiesMember2023-07-012023-09-300001412100us-gaap:FixedIncomeSecuritiesMember2024-01-012024-09-300001412100us-gaap:FixedIncomeSecuritiesMember2023-01-012023-09-300001412100mhld:FundsWithheldArrangementMember2024-07-012024-09-300001412100mhld:FundsWithheldArrangementMember2023-07-012023-09-300001412100mhld:FundsWithheldArrangementMember2024-01-012024-09-300001412100mhld:FundsWithheldArrangementMember2023-01-012023-09-300001412100mhld:NotesReceivableRelatedPartyMember2024-07-012024-09-300001412100mhld:NotesReceivableRelatedPartyMember2023-07-012023-09-300001412100mhld:NotesReceivableRelatedPartyMember2024-01-012024-09-300001412100mhld:NotesReceivableRelatedPartyMember2023-01-012023-09-300001412100mhld:OtherInvestmentMember2024-07-012024-09-300001412100mhld:OtherInvestmentMember2023-07-012023-09-300001412100mhld:OtherInvestmentMember2024-01-012024-09-300001412100mhld:OtherInvestmentMember2023-01-012023-09-300001412100mhld:CashAndCashEquivalentsAndOtherMember2024-07-012024-09-300001412100mhld:CashAndCashEquivalentsAndOtherMember2023-07-012023-09-300001412100mhld:CashAndCashEquivalentsAndOtherMember2024-01-012024-09-300001412100mhld:CashAndCashEquivalentsAndOtherMember2023-01-012023-09-300001412100us-gaap:FixedMaturitiesMember2024-07-012024-09-300001412100us-gaap:OtherDebtSecuritiesMember2024-07-012024-09-300001412100us-gaap:FixedMaturitiesMember2023-07-012023-09-300001412100us-gaap:OtherDebtSecuritiesMember2023-07-012023-09-300001412100us-gaap:FixedMaturitiesMember2024-01-012024-09-300001412100us-gaap:OtherDebtSecuritiesMember2024-01-012024-09-300001412100us-gaap:FixedMaturitiesMember2023-01-012023-09-300001412100us-gaap:OtherDebtSecuritiesMember2023-01-012023-09-300001412100us-gaap:FixedMaturitiesMember2024-09-300001412100us-gaap:FixedMaturitiesMember2023-12-310001412100mhld:ThirdPartyAgreementsMember2024-09-300001412100mhld:ThirdPartyAgreementsMember2023-12-310001412100mhld:RelatedPartyAgreementsMember2024-09-300001412100mhld:RelatedPartyAgreementsMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001412100us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMember2024-09-300001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-12-310001412100us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001412100us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001412100us-gaap:FairValueMeasurementsRecurringMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001412100us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedMaturitiesMember2024-09-300001412100us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedMaturitiesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:FixedMaturitiesMember2023-12-310001412100us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Membermhld:PrivatelyHeldEquitySecuritiesInCommonStockMemberus-gaap:CommonStockMembermhld:ValuationTechniqueQuarterlyFinancialStatementsMember2024-09-300001412100us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Membermhld:PrivatelyHeldEquityInvestmentsInPreferredStockMemberus-gaap:PreferredStockMembermhld:ValuationTechniqueQuarterlyFinancialStatementsMember2024-09-300001412100us-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMember2024-09-300001412100us-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMember2024-09-3000014121002024-06-3000014121002023-06-300001412100mhld:SeniorNotes2016Memberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2016Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2016Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2016Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2016Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2023-12-310001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2013Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2013Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2013Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Membermhld:SeniorNotes2013Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001412100us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001412100us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-3100014121002023-05-0200014121002023-05-030001412100mhld:NonPerformanceBasedRestrictedSharesMember2024-09-300001412100mhld:A2019OmnibusIncentivePlanMember2024-09-300001412100mhld:ShareRepurchasePlanMemberus-gaap:CommonStockMember2017-02-210001412100mhld:ShareRepurchasePlanMember2024-07-012024-09-300001412100mhld:ShareRepurchasePlanMember2024-01-012024-09-300001412100mhld:ShareRepurchasePlanMember2023-07-012023-09-300001412100mhld:ShareRepurchasePlanMember2023-01-012023-09-300001412100mhld:ShareRepurchasePlanMember2024-09-300001412100mhld:ShareRepurchasePlanMember2023-12-310001412100mhld:EmployeesTaxWithholdingMember2024-01-012024-09-300001412100mhld:EmployeesTaxWithholdingMember2023-01-012023-09-300001412100mhld:MaidenReinsuranceMember2024-09-300001412100mhld:ExchangeForPreferredSharesMembermhld:MaidenReinsuranceMember2024-09-300001412100mhld:ExchangeForPreferredSharesMembermhld:MaidenReinsuranceMember2023-12-310001412100mhld:ShareRepurchasePlanMembermhld:MaidenReinsuranceMember2024-01-012024-09-300001412100mhld:MaidenReinsuranceMember2023-12-310001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-07-012024-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001412100us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001412100us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001412100us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300001412100us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001412100us-gaap:SeniorNotesMember2024-09-300001412100mhld:SeniorNotes2016Memberus-gaap:SeniorNotesMember2023-12-310001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2023-12-310001412100us-gaap:SeniorNotesMember2023-12-310001412100us-gaap:SeniorNotesMember2024-07-012024-09-300001412100us-gaap:SeniorNotesMember2024-01-012024-09-300001412100us-gaap:SeniorNotesMember2023-07-012023-09-300001412100us-gaap:SeniorNotesMember2023-01-012023-09-300001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2024-01-012024-09-300001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMembersrt:MinimumMember2024-01-012024-09-300001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMembersrt:MaximumMember2024-01-012024-09-300001412100mhld:SeniorNotes2016Memberus-gaap:SeniorNotesMember2024-01-012024-09-300001412100mhld:SeniorNotes2016Memberus-gaap:SeniorNotesMembersrt:MinimumMember2024-01-012024-09-300001412100mhld:SeniorNotes2016Memberus-gaap:SeniorNotesMembersrt:MaximumMember2024-01-012024-09-300001412100us-gaap:SeniorNotesMember2023-05-030001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2023-01-012023-09-300001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2023-09-300001412100mhld:SeniorNotes2013Memberus-gaap:SeniorNotesMember2023-07-012023-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2018-12-2700014121002019-07-312019-07-3100014121002019-07-3100014121002018-12-310001412100srt:MaximumMember2024-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:DiversifiedReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:AmTrustQuotaShareMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:AmTrustQuotaShareMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:AmTrustQuotaShareMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:AmTrustQuotaShareMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:AmTrustOtherRunoffMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:AmTrustOtherRunoffMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:AmTrustOtherRunoffMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:AmTrustOtherRunoffMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:EuropeanHospitalLiabilityQuotaShareAgreementMembermhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:EuropeanHospitalLiabilityQuotaShareAgreementMembermhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:EuropeanHospitalLiabilityQuotaShareAgreementMembermhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:EuropeanHospitalLiabilityQuotaShareAgreementMembermhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:AmTrustReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:AmTrustReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:AmTrustReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:AmTrustReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:AmtrustQuotaShareReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:MaidenHoldingsLtd.Membermhld:GeorgeKarfunkelMember2024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FoundingShareholdersMember2024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2007-07-012007-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2008-06-112008-06-110001412100mhld:AELMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2018-07-010001412100mhld:AmtrustFinancialServicesIncMembersrt:MinimumMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2013-07-012013-07-010001412100mhld:AmtrustFinancialServicesIncMembersrt:MaximumMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2013-07-012013-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2013-07-012013-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:PostTerminationEndorsementMaximumLossCorridorMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-07-312019-07-310001412100mhld:AmtrustFinancialServicesIncMembermhld:AmTrustQuotaSharesReinsuranceAgreementPartialTerminationAmendmentMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2018-12-312018-12-310001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-07-312019-07-310001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2011-04-012011-04-010001412100mhld:AmtrustFinancialServicesIncMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2012-01-012012-01-010001412100mhld:AmtrustFinancialServicesIncMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2016-07-012016-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2022-07-012022-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2022-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:AmTrustReinsuranceSegmentMembermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2022-07-012022-07-010001412100mhld:AmtrustFinancialServicesIncMembermhld:QuotaShareReinsuranceAgreementsMember2024-07-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:QuotaShareReinsuranceAgreementsMember2023-07-012023-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:QuotaShareReinsuranceAgreementsMember2024-01-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:QuotaShareReinsuranceAgreementsMember2023-01-012023-09-300001412100mhld:AmtrustFinancialServicesIncMember2023-12-310001412100mhld:AmtrustFinancialServicesIncMember2024-09-300001412100mhld:AmtrustFinancialServicesIncMember2023-01-012023-12-310001412100mhld:AmtrustFinancialServicesIncMember2024-01-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-01-112019-01-110001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2024-01-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2023-01-012023-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2023-01-012023-12-310001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2023-12-310001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2024-07-012024-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:FundsWithheldArrangementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2023-07-012023-09-300001412100mhld:AmtrustFinancialServicesIncMembermhld:PostTerminationEndorsementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-07-312019-07-310001412100mhld:AmtrustFinancialServicesIncMembermhld:PostTerminationEndorsementMinimumExcessFundingRequirementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-07-312019-07-310001412100mhld:AmtrustFinancialServicesIncMembersrt:MaximumMembermhld:PostTerminationEndorsementMembermhld:AmtrustQuotaShareReinsuranceSegmentMember2019-07-312019-07-310001412100mhld:AmtrustFinancialServicesIncMembermhld:PostTerminationEndorsementNo.2Membermhld:AmtrustQuotaShareReinsuranceSegmentMember2020-03-162020-03-160001412100mhld:AmtrustFinancialServicesIncMembermhld:PostTerminationEndorsementNo.2Membermhld:AmtrustQuotaShareReinsuranceSegmentMember2023-01-012023-03-310001412100mhld:AmtrustFinancialServicesIncMembersrt:MaximumMembermhld:PostTerminationEndorsementNo.1Membermhld:EuropeanHospitalLiabilityQuotaShareAgreementMember2020-03-162020-03-160001412100mhld:AELMembermhld:AmtrustEuropeanHospitalLiabilityQuotaShareAgreementMember2024-09-300001412100mhld:AELMembermhld:AmtrustEuropeanHospitalLiabilityQuotaShareAgreementMember2023-12-310001412100mhld:AmtrustFinancialServicesIncMembermhld:AssetManagementAgreementMember2018-01-012018-01-010001412100mhld:InvestmentManagementFeesMembermhld:AmtrustFinancialServicesIncMembermhld:AssetManagementAgreementMember2024-07-012024-09-300001412100mhld:InvestmentManagementFeesMembermhld:AmtrustFinancialServicesIncMembermhld:AssetManagementAgreementMember2024-01-012024-09-300001412100mhld:InvestmentManagementFeesMembermhld:AmtrustFinancialServicesIncMembermhld:AssetManagementAgreementMember2023-07-012023-09-300001412100mhld:InvestmentManagementFeesMembermhld:AmtrustFinancialServicesIncMembermhld:AssetManagementAgreementMember2023-01-012023-09-300001412100mhld:AlternativeInvestmentMember2023-12-310001412100mhld:AlternativeInvestmentMember2024-09-300001412100us-gaap:PrivateEquityFundsMember2024-09-300001412100us-gaap:PrivateEquityFundsMember2023-12-310001412100mhld:PrivateCreditLendingMember2024-09-300001412100mhld:PrivateCreditLendingMember2023-12-310001412100mhld:DirectLendingEntitiesMember2024-09-300001412100mhld:DirectLendingEntitiesMember2023-12-310001412100us-gaap:OtherInvestmentsMember2024-09-300001412100us-gaap:OtherInvestmentsMember2023-12-310001412100us-gaap:EquitySecuritiesMember2024-09-300001412100us-gaap:EquitySecuritiesMember2023-12-310001412100us-gaap:EquityMethodInvestmentsMember2024-09-300001412100us-gaap:EquityMethodInvestmentsMember2023-12-310001412100us-gaap:InternalRevenueServiceIRSMember2024-09-300001412100us-gaap:InternalRevenueServiceIRSMember2023-12-31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2024
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _________ to _________
Commission File No. 001-34042
MAIDEN HOLDINGS, LTD.
(Exact name of registrant as specified in its charter)
| | | | | |
Bermuda | 98-0570192 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
94 Pitts Bay Road | |
Pembroke | |
Bermuda | HM08 |
(Address of principal executive offices) | (Zip Code) |
(441) 298-4900
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of Each Class | | Trading symbol(s) | | Name of Each Exchange on Which Registered |
Common Shares, par value $0.01 per share | | MHLD | | NASDAQ Capital Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | |
Large accelerated filer | ☐ | | Accelerated filer | ☒ |
Non-accelerated filer | ☐ | | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act).
Yes ☐ No ☒
As of November 7, 2024, 99,320,805 common shares were outstanding. 143,789,931 common shares, par value $0.01 per share, were outstanding when the ownership by our affiliate Maiden Reinsurance Ltd. of 44,469,126 common shares were included. These affiliated shares are treated as treasury shares and are not included in the computation of consolidated book value and earnings per common share.
INDEX
| | | | | | | | |
| | |
| | |
| | |
| | |
| | Page |
PART I - Financial Information | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
PART II - Other Information | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
MAIDEN HOLDINGS, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share data)
| | | | | | | | | | | | | | |
| | September 30, 2024 | | December 31, 2023 |
ASSETS | | (Unaudited) | | (Audited) |
Investments: | | | | |
Fixed maturities, available-for-sale, at fair value (Amortized cost: 2024 - $229,759; 2023 - $258,536) | | $ | 225,756 | | | $ | 250,601 | |
Equity securities, at fair value (Cost: 2024 - $16,987; 2023 - $43,439) | | 19,311 | | | 45,299 | |
Equity method investments | | 86,236 | | | 80,929 | |
Other investments (Allowance for expected credit losses: 2024 - $1,023; 2023 - $1,023) | | 147,823 | | | 182,811 | |
Total investments | | 479,126 | | | 559,640 | |
Cash and cash equivalents | | 109,965 | | | 35,412 | |
Restricted cash and cash equivalents | | 17,823 | | | 7,266 | |
Accrued investment income | | 3,724 | | | 4,532 | |
Reinsurance balances receivable, net (includes $6,300 and $9,201 from related parties in 2024 and 2023, respectively. Allowance for expected credit losses: 2024 - $211; 2023 - $187) | | 9,875 | | | 12,450 | |
Reinsurance recoverable on unpaid losses (Allowance for expected credit losses: 2024 - $2,331; 2023 - $3,240) | | 574,358 | | | 564,331 | |
Loan to related party | | 167,975 | | | 167,975 | |
Deferred commission and other acquisition expenses (includes $8,449 and $16,605 from related parties in 2024 and 2023, respectively) | | 9,226 | | | 17,566 | |
Funds withheld receivable (includes $0 and $128,451 from related parties in 2024 and 2023, respectively. Allowance for expected credit losses: 2024 - $19; 2023 - $19) | | 14,815 | | | 143,985 | |
Other assets | | 6,624 | | | 5,777 | |
| | | | |
Total assets | | $ | 1,393,511 | | | $ | 1,518,934 | |
LIABILITIES | | | | |
Reserve for loss and loss adjustment expenses (includes $613,425 and $752,991 from related parties in 2024 and 2023, respectively) | | $ | 721,436 | | | $ | 867,433 | |
Unearned premiums (includes $32,744 and $44,577 from related parties in 2024 and 2023, respectively) | | 33,883 | | | 46,260 | |
Deferred gain on retroactive reinsurance | | 90,321 | | | 73,240 | |
Liability for securities purchased | | 10,980 | | | — | |
Accrued expenses and other liabilities (includes $53,712 and $10,781 from related parties in 2024 and 2023, respectively) | | 73,994 | | | 28,244 | |
Senior notes - principal amount | | 262,361 | | | 262,361 | |
Less: unamortized debt issuance costs | | 7,646 | | | 7,764 | |
Senior notes, net | | 254,715 | | | 254,597 | |
| | | | |
Total liabilities | | 1,185,329 | | | 1,269,774 | |
Commitments and Contingencies | | | | |
EQUITY | | | | |
| | | | |
Common shares ($0.01 par value; 2024: 150,298,798 and 2023: 149,732,355 shares issued; 2024: 99,422,608 and 2023: 100,472,120 shares outstanding) | | 1,503 | | | 1,497 | |
Additional paid-in capital | | 887,520 | | | 886,072 | |
Accumulated other comprehensive loss | | (27,788) | | | (31,469) | |
Accumulated deficit | | (529,925) | | | (486,945) | |
Treasury shares, at cost (2024: 50,876,190 shares and 2023: 49,260,235 shares) | | (123,128) | | | (119,995) | |
Total shareholders’ equity | | 208,182 | | | 249,160 | |
| | | | |
| | | | |
Total liabilities and equity | | $ | 1,393,511 | | | $ | 1,518,934 | |
See accompanying notes to the unaudited Condensed Consolidated Financial Statements.
MAIDEN HOLDINGS, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(in thousands of U.S. dollars, except per share data)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, |
| | 2024 | | 2023 | | 2024 | | 2023 |
Revenues | | | | | | | | |
Gross premiums written | | $ | 8,861 | | | $ | 8,660 | | | $ | 25,633 | | | $ | 16,371 | |
Net premiums written | | $ | 8,843 | | | $ | 8,625 | | | $ | 25,496 | | | $ | 16,260 | |
Change in unearned premiums | | 4,560 | | | 3,854 | | | 12,392 | | | 16,260 | |
Net premiums earned | | 13,403 | | | 12,479 | | | 37,888 | | | 32,520 | |
Other insurance (expense) revenue , net | | — | | | (16) | | | 46 | | | 3 | |
Net investment income | | 4,878 | | | 9,048 | | | 19,531 | | | 29,111 | |
Net realized and unrealized investment (losses) gains | | (3,804) | | | 244 | | | 6,403 | | | 2,394 | |
| | | | | | | | |
Total revenues | | 14,477 | | | 21,755 | | | 63,868 | | | 64,028 | |
Expenses | | | | | | | | |
Net loss and loss adjustment expenses | | 19,857 | | | 15,156 | | | 45,453 | | | 36,503 | |
Commission and other acquisition expenses | | 9,068 | | | 5,340 | | | 19,474 | | | 14,520 | |
General and administrative expenses | | 10,014 | | | 6,787 | | | 25,953 | | | 23,734 | |
Interest and amortization expenses | | 4,817 | | | 4,814 | | | 14,448 | | | 13,411 | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange and other losses (gains) | | 5,915 | | | (4,594) | | | 3,862 | | | 843 | |
Total expenses | | 49,671 | | | 27,503 | | | 109,190 | | | 89,011 | |
Loss before income taxes and interest in income of equity method investments | | (35,194) | | | (5,748) | | | (45,322) | | | (24,983) | |
Less: income tax expense (benefit) | | 25 | | | (31) | | | 478 | | | (253) | |
Interest in income of equity method investments | | 751 | | | 2,190 | | | 2,820 | | | 6,942 | |
| | | | | | | | |
| | | | | | | | |
Net loss | | $ | (34,468) | | | $ | (3,527) | | | $ | (42,980) | | | $ | (17,788) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Basic and diluted loss per share attributable to common shareholders | | $ | (0.35) | | | $ | (0.03) | | | $ | (0.43) | | | $ | (0.18) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Weighted average number of common shares - basic and diluted | | 99,724,474 | | | 101,454,767 | | | 100,112,436 | | | 101,586,759 | |
| | | | | | | | |
See accompanying notes to the unaudited Condensed Consolidated Financial Statements.
MAIDEN HOLDINGS, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(in thousands of U.S. dollars)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, |
| | 2024 | | 2023 | | 2024 | | 2023 |
Net loss | | $ | (34,468) | | | $ | (3,527) | | | $ | (42,980) | | | $ | (17,788) | |
Other comprehensive income (loss) | | | | | | | | |
Net unrealized holdings gains on AFS securities | | 2,427 | | | 338 | | | 3,932 | | | 3,121 | |
| | | | | | | | |
| | | | | | | | |
Adjustment for reclassification of net realized gains recognized in net loss | | — | | | (3) | | | — | | | (3) | |
Foreign currency translation adjustment | | 2,304 | | | (2,075) | | | (207) | | | (741) | |
Other comprehensive income (loss), before tax | | 4,731 | | | (1,740) | | | 3,725 | | | 2,377 | |
Income tax expense related to components of other comprehensive income (loss) | | (34) | | | (17) | | | (44) | | | (36) | |
Other comprehensive income (loss), after tax | | 4,697 | | | (1,757) | | | 3,681 | | | 2,341 | |
Comprehensive loss | | $ | (29,771) | | | $ | (5,284) | | | $ | (39,299) | | | $ | (15,447) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
See accompanying notes to the unaudited Condensed Consolidated Financial Statements.
MAIDEN HOLDINGS, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)
(in thousands of U.S. dollars)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, |
| | 2024 | | 2023 | | 2024 | | 2023 |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Common shares | | | | | | | | |
Beginning balance | | $ | 1,503 | | | $ | 1,497 | | | $ | 1,497 | | | $ | 1,492 | |
| | | | | | | | |
Issuance of common shares from vesting of stock based compensation | | — | | | — | | | 6 | | | 5 | |
Ending balance | | 1,503 | | | 1,497 | | | 1,503 | | | 1,497 | |
Additional paid-in capital | | | | | | | | |
Beginning balance | | 886,972 | | | 885,462 | | | 886,072 | | | 884,259 | |
Issuance of common shares from vesting of stock based compensation | | — | | | — | | | (6) | | | (5) | |
Share-based compensation expense | | 548 | | | 286 | | | 1,454 | | | 1,401 | |
Repurchase of preference shares | | — | | | — | | | — | | | 93 | |
| | | | | | | | |
| | | | | | | | |
Ending balance | | 887,520 | | | 885,748 | | | 887,520 | | | 885,748 | |
Accumulated other comprehensive loss | | | | | | | | |
Beginning balance | | (32,485) | | | (37,136) | | | (31,469) | | | (41,234) | |
Change in net unrealized investment gains | | 2,393 | | | 318 | | | 3,888 | | | 3,082 | |
Foreign currency translation adjustment | | 2,304 | | | (2,075) | | | (207) | | | (741) | |
Ending balance | | (27,788) | | | (38,893) | | | (27,788) | | | (38,893) | |
Accumulated deficit | | | | | | | | |
Beginning balance | | (495,457) | | | (462,637) | | | (486,945) | | | (442,863) | |
Opening allowance for expected credit losses | | — | | | — | | | — | | | (5,513) | |
Net loss | | (34,468) | | | (3,527) | | | (42,980) | | | (17,788) | |
| | | | | | | | |
| | | | | | | | |
Ending balance | | (529,925) | | | (466,164) | | | (529,925) | | | (466,164) | |
Treasury shares | | | | | | | | |
Beginning balance | | (122,487) | | | (117,896) | | | (119,995) | | | (117,075) | |
| | | | | | | | |
Shares repurchased | | (641) | | | (1,055) | | | (3,133) | | | (1,876) | |
Ending balance | | (123,128) | | | (118,951) | | | (123,128) | | | (118,951) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Total shareholders' equity | | $ | 208,182 | | | $ | 263,237 | | | $ | 208,182 | | | $ | 263,237 | |
See accompanying notes to the unaudited Condensed Consolidated Financial Statements.
MAIDEN HOLDINGS, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands of U.S. dollars)
| | | | | | | | | | | | | | |
For the Nine Months Ended September 30, | | 2024 | | 2023 |
Cash flows from operating activities | | | | |
Net loss | | $ | (42,980) | | | $ | (17,788) | |
| | | | |
Adjustments to reconcile net loss to net cash flows from operating activities: | | | | |
Other non-cash expenses including depreciation, amortization and share-based compensation | | (590) | | | (890) | |
Interest in income of equity method investments | | (2,820) | | | (6,942) | |
Net realized and unrealized investment gains | | (6,403) | | | (2,394) | |
Change in allowance for expected credit losses | | (890) | | | (23) | |
Foreign exchange and other losses | | 3,862 | | | 843 | |
Changes in assets – (increase) decrease: | | | | |
Reinsurance balances receivable, net | | 2,516 | | | 177 | |
Reinsurance recoverable on unpaid losses | | 8,005 | | | 4,060 | |
Accrued investment income | | 822 | | | (1,391) | |
Deferred commission and other acquisition expenses | | 8,342 | | | 5,797 | |
Funds withheld receivable | | 14,726 | | | 1,683 | |
Other assets | | 905 | | | 411 | |
Changes in liabilities – increase (decrease): | | | | |
Reserve for loss and loss adjustment expenses | | (35,627) | | | (9,086) | |
Unearned premiums | | (12,372) | | | (16,264) | |
| | | | |
Accrued expenses and other liabilities | | 43,348 | | | (24,190) | |
| | | | |
| | | | |
Net cash used in operating activities | | (19,156) | | | (65,997) | |
Cash flows from investing activities: | | | | |
Purchases of fixed maturities | | (329,717) | | | (47,373) | |
Purchases of other investments | | (23,488) | | | (33,287) | |
Purchases of equity method investments | | (7,693) | | | (10,288) | |
Purchases of equity securities | | — | | | (1,448) | |
Proceeds from sales of fixed maturities | | 50,299 | | | 64,126 | |
Proceeds from maturities, paydowns and calls of fixed maturities | | 321,791 | | | 43,903 | |
Proceeds from sale and redemption of other investments | | 68,199 | | | 17,229 | |
Proceeds from sale and redemption of equity method investments | | 4,658 | | | 17,843 | |
Proceeds from sale and redemption of equity securities | | 23,392 | | | 469 | |
| | | | |
Others, net | | (367) | | | (37) | |
| | | | |
| | | | |
Net cash provided by investing activities | | 107,074 | | | 51,137 | |
Cash flows from financing activities: | | | | |
Repurchase of common shares | | (3,133) | | | (1,876) | |
| | | | |
| | | | |
| | | | |
| | | | |
Repurchase of senior notes | | — | | | (95) | |
| | | | |
Net cash used in financing activities | | (3,133) | | | (1,971) | |
Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents | | 325 | | | (263) | |
Net increase (decrease) in cash, restricted cash and cash equivalents | | 85,110 | | | (17,094) | |
Cash, restricted cash and cash equivalents, beginning of period | | 42,678 | | | 46,624 | |
Cash, restricted cash and cash equivalents, end of period | | $ | 127,788 | | | $ | 29,530 | |
| | | | |
| | | | |
Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets: | | | | |
Cash and cash equivalents, end of period | | $ | 109,965 | | | $ | 17,930 | |
Restricted cash and cash equivalents, end of period | | 17,823 | | | 11,600 | |
Total cash, restricted cash and cash equivalents, end of period | | $ | 127,788 | | | $ | 29,530 | |
| | | | |
| | | | |
| | | | |
| | | | |
See accompanying notes to the unaudited Condensed Consolidated Financial Statements.
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
1. Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Maiden Holdings, Ltd. ("Parent Company" or "Maiden Holdings") and its subsidiaries (the "Company" or "Maiden"). They have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X as promulgated by the U.S. Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. All significant intercompany transactions and accounts have been eliminated.
These interim unaudited Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
These unaudited Condensed Consolidated Financial Statements, including these notes, should be read in conjunction with the Company's audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. Certain prior year comparatives have been reclassified to conform to the current period presentation. The effect of these reclassifications had no impact on previously reported shareholders' equity or net income.
Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets primarily in the insurance and related financial services industries where we can leverage our deep knowledge of those markets.
In November 2020, the Company formed our indirect wholly owned subsidiary Genesis Legacy Solutions ("GLS") which specialized in providing a full range of legacy services to small insurance entities, particularly those in run-off or with blocks of reserves that are no longer core to those companies' operations, working with clients to develop and implement finality solutions including acquiring entire companies. The Company believed the formation of GLS was highly complementary to its overall longer-term strategy. However, a combination of factors, including market conditions in the sector GLS focuses on, resulted in an inability for GLS to gain sufficient scale to achieve its objectives or earn a profit, and GLS results did not reach the objectives the Company expected it to over time. Having completed the capital commitment made to GLS in 2020, the Company has determined to not commit any additional capital to new opportunities and to run-off the existing accounts underwritten by GLS. The Company does not presently underwrite prospective reinsurance risks.
Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Our wholly owned subsidiary, Maiden Global Holdings Ltd. (“Maiden Global”) is a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in Europe and other global markets ("IIS business"). These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd. (“Maiden Reinsurance”). Since 2023, the Company has been evaluating the strategic value of Maiden LF and Maiden GF in relation to their ongoing growth and profitability prospects, regulatory capital requirements and ability to create shareholder value in excess of our target return on capital levels. On May 3, 2024, Maiden LF and Maiden GF entered into a Renewal Rights and Asset Purchase Agreement with AmTrust Nordic AB, a Swedish unit of AmTrust Financial Services, Inc. ("AmTrust") which is expected to cover certain programs of Maiden LF and Maiden GF's primary business written in Sweden, Norway and other Nordic countries. On June 20, 2024, Maiden LF and Maiden GF entered into a Renewal Rights and Asset Purchase Agreement with AmTrust Europe Limited ("AEL") and AmTrust International Underwriters DAC ("AIU DAC"), both wholly owned subsidiaries of AmTrust, which is expected to cover certain programs of Maiden LF and Maiden GF's primary business written in the United Kingdom and Ireland. These agreements are collectively referred to as the "AmTrust Renewal Rights Agreements". Under these agreements, those AmTrust subsidiaries in collaboration with existing Maiden LF and Maiden GF distribution partners, will offer renewals to select policyholders in exchange for a fee at standard market terms for business successfully renewed. All programs written by Maiden LF and GF, including those covered by the AmTrust Renewal Rights Agreements, are in the process of being cancelled in accordance with the requirements of the AmTrust Renewal Rights Agreements, or their contractual terms.
These transactions are part of the Company's broader plan to divest its IIS businesses as a result of its recently concluded strategic review of the IIS business platform. The purpose of that review was to evaluate the strategic value of Maiden LF and Maiden GF in relation to their ongoing growth and profitability prospects, regulatory capital requirements and ability to create shareholder value in excess of the Company's target return on capital levels. As part of these conclusions, the Company expects to enter into additional transactions to either sell or wind-up Maiden GF and Maiden LF and is actively evaluating potential transactions. Please see "Note 10. Related Party Transactions" for details regarding the Renewal Rights Agreement.
The Company also has various historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off, including the liabilities associated with AmTrust reinsurance agreements which were terminated in 2019 as discussed in "Note 10. Related Party Transactions". In addition, the Company has a retroactive reinsurance agreement and a commutation agreement that further reduces its exposure and limits the potential volatility related to AmTrust liabilities, which are discussed in "Note 8. Reinsurance". Please also see the Company's audited Consolidated Financial Statements, and related notes thereto, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 for further details.
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
2. Significant Accounting Policies
There have been no material changes to the significant accounting policies as described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, except for the following:
Recently Adopted Accounting Standards
Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions
In June 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-03 "Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions" an amendment of Fair Value Measurement (Topic 820). The amendments in this ASU require the Company to provide disclosures for equity securities subject to contractual sale restrictions under 820-10-50-6B including the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restrictions; and any circumstances that could cause a lapse in the restrictions. The amendments in this Update are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company adopted this Update on January 1, 2024.
Certain of the Company's equity securities are subject to restrictions on redemptions and sales that are determined by the governing documents, which could limit our ability to liquidate those investments. These restrictions may include lock-ups, redemption gates, restricted share classes, restrictions on the frequency of redemption and notice periods as described in "Note 4. (b) Investments". The Company has assessed the required disclosures for equity securities that may be subject to contractual sales restrictions. These amendments have expanded the disclosures made in "Note 4. Investments" however the adoption of this standard did not impact the Company’s condensed consolidated balance sheets, results of operations or statement of cash flows.
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information
The Company currently has two reportable segments: Diversified Reinsurance and AmTrust Reinsurance. Our Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe. This segment also includes transactions entered into by GLS as described in "Note 1. Basis of Presentation". Our AmTrust Reinsurance segment includes all business ceded to Maiden Reinsurance by AmTrust, primarily the quota share reinsurance agreement (“AmTrust Quota Share”) between Maiden Reinsurance and AmTrust’s wholly owned subsidiary, AmTrust International Insurance, Ltd. (“AII”) and the European hospital liability quota share reinsurance contract ("European Hospital Liability Quota Share") with AmTrust’s wholly owned subsidiaries, AEL and AIU DAC, which are both in run-off effective January 1, 2019. Please refer to "Note 10. Related Party Transactions" for additional information regarding the AmTrust Reinsurance segment.
The Company evaluates segment performance based on segment profit separately from the results of our investment portfolio. General and administrative expenses are allocated to the segments on an actual basis except salaries and benefits where management’s judgment is applied; however, general corporate expenses are not allocated to the segments. In determining total assets by reportable segment, the Company identifies those assets that are attributable to a particular segment such as reinsurance balances receivable, reinsurance recoverable on unpaid losses, deferred commission and other acquisition expenses, funds withheld receivable, loan to related party and restricted cash and investments. All remaining assets are allocated to Corporate.
The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net loss for the three months ended September 30, 2024 and 2023, respectively:
| | | | | | | | | | | | | | | | | | | | | | |
For the Three Months Ended September 30, 2024 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 9,053 | | | $ | (192) | | | | | $ | 8,861 | |
Net premiums written | | $ | 9,035 | | | $ | (192) | | | | | $ | 8,843 | |
Net premiums earned | | $ | 9,576 | | | $ | 3,827 | | | | | $ | 13,403 | |
| | | | | | | | |
Net loss and LAE | | (4,036) | | | (15,821) | | | | | (19,857) | |
Commission and other acquisition expenses | | (3,975) | | | (5,093) | | | | | (9,068) | |
General and administrative expenses | | (2,512) | | | (717) | | | | | (3,229) | |
Underwriting loss | | $ | (947) | | | $ | (17,804) | | | | | (18,751) | |
Reconciliation to net loss | | | | | | | | |
Net investment income and net realized and unrealized investment losses | | | | | | | | 1,074 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (4,817) | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange and other losses, net | | | | | | | | (5,915) | |
Other general and administrative expenses | | | | | | | | (6,785) | |
Income tax expense | | | | | | | | (25) | |
Interest in income of equity method investments | | | | | | | | 751 | |
Net loss | | | | | | | | $ | (34,468) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information (continued)
| | | | | | | | | | | | | | | | | | | | | | |
For the Three Months Ended September 30, 2023 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 6,762 | | | $ | 1,898 | | | | | $ | 8,660 | |
Net premiums written | | $ | 6,727 | | | $ | 1,898 | | | | | $ | 8,625 | |
Net premiums earned | | $ | 7,207 | | | $ | 5,272 | | | | | $ | 12,479 | |
Other insurance expense | | (16) | | | — | | | | | (16) | |
Net loss and LAE | | (4,142) | | | (11,014) | | | | | (15,156) | |
Commission and other acquisition expenses | | (3,374) | | | (1,966) | | | | | (5,340) | |
General and administrative expenses | | (2,216) | | | (661) | | | | | (2,877) | |
Underwriting loss | | $ | (2,541) | | | $ | (8,369) | | | | | (10,910) | |
Reconciliation to net loss | | | | | | | | |
Net investment income and net realized and unrealized investment gains | | | | | | | | 9,292 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (4,814) | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange and other gains, net | | | | | | | | 4,594 | |
Other general and administrative expenses | | | | | | | | (3,910) | |
Income tax benefit | | | | | | | | 31 | |
Interest in income from equity method investments | | | | | | | | 2,190 | |
Net loss | | | | | | | | $ | (3,527) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net loss for the nine months ended September 30, 2024 and 2023, respectively:
| | | | | | | | | | | | | | | | | | | | | | |
For the Nine Months Ended September 30, 2024 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 26,374 | | | $ | (741) | | | | | $ | 25,633 | |
Net premiums written | | $ | 26,237 | | | $ | (741) | | | | | $ | 25,496 | |
Net premiums earned | | $ | 26,796 | | | $ | 11,092 | | | | | $ | 37,888 | |
Other insurance revenue | | 46 | | | — | | | | | 46 | |
Net loss and LAE | | (12,314) | | | (33,139) | | | | | (45,453) | |
Commission and other acquisition expenses | | (11,564) | | | (7,910) | | | | | (19,474) | |
General and administrative expenses | | (6,960) | | | (2,087) | | | | | (9,047) | |
Underwriting loss | | $ | (3,996) | | | $ | (32,044) | | | | | (36,040) | |
Reconciliation to net loss | | | | | | | | |
Net investment income and net realized and unrealized investment gains | | | | | | | | 25,934 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (14,448) | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange and other losses, net | | | | | | | | (3,862) | |
Other general and administrative expenses | | | | | | | | (16,906) | |
Income tax expense | | | | | | | | (478) | |
Interest in income from equity method investments | | | | | | | | 2,820 | |
Net loss | | | | | | | | $ | (42,980) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information (continued)
| | | | | | | | | | | | | | | | | | | | | | |
For the Nine Months Ended September 30, 2023 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 20,263 | | | $ | (3,892) | | | | | $ | 16,371 | |
Net premiums written | | $ | 20,152 | | | $ | (3,892) | | | | | $ | 16,260 | |
Net premiums earned | | $ | 21,882 | | | $ | 10,638 | | | | | $ | 32,520 | |
Other insurance revenue | | 3 | | | — | | | | | 3 | |
Net loss and LAE | | (11,126) | | | (25,377) | | | | | (36,503) | |
Commission and other acquisition expenses | | (10,544) | | | (3,976) | | | | | (14,520) | |
General and administrative expenses | | (7,863) | | | (2,062) | | | | | (9,925) | |
Underwriting loss | | $ | (7,648) | | | $ | (20,777) | | | | | (28,425) | |
Reconciliation to net loss | | | | | | | | |
Net investment income and net realized and unrealized investment gains | | | | | | | | 31,505 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (13,411) | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange and other losses, net | | | | | | | | (843) | |
Other general and administrative expenses | | | | | | | | (13,809) | |
Income tax benefit | | | | | | | | 253 | |
Interest in income from equity method investments | | | | | | | | 6,942 | |
Net loss | | | | | | | | $ | (17,788) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information (continued)
The following tables summarize the financial position of the Company's reportable segments including a reconciliation to the Company's consolidated total assets at September 30, 2024 and December 31, 2023:
| | | | | | | | | | | | | | | | | | | | |
September 30, 2024 | | Diversified Reinsurance | | AmTrust Reinsurance | | Total |
Reinsurance balances receivable, net | | $ | 3,533 | | | $ | 6,300 | | | $ | 9,833 | |
Reinsurance recoverable on unpaid losses | | 4,647 | | | 532,874 | | | 537,521 | |
Deferred commission and other acquisition expenses | | 777 | | | 8,449 | | | 9,226 | |
Loan to related party | | — | | | 167,975 | | | 167,975 | |
| | | | | | |
Restricted cash and cash equivalents and investments | | 65,946 | | | 147,715 | | | 213,661 | |
Funds withheld receivable | | 14,815 | | | — | | | 14,815 | |
Other assets | | 646 | | | — | | | 646 | |
Total assets - reportable segments | | 90,364 | | | 863,313 | | | 953,677 | |
Corporate assets | | — | | | — | | | 439,834 | |
| | | | | | |
Total Assets | | $ | 90,364 | | | $ | 863,313 | | | $ | 1,393,511 | |
| | | | | | |
December 31, 2023 | | Diversified Reinsurance | | AmTrust Reinsurance | | Total |
Reinsurance balances receivable, net | | $ | 3,108 | | | $ | 9,201 | | | $ | 12,309 | |
Reinsurance recoverable on unpaid losses | | 5,692 | | | 515,463 | | | 521,155 | |
Deferred commission and other acquisition expenses | | 961 | | | 16,605 | | | 17,566 | |
Loan to related party | | — | | | 167,975 | | | 167,975 | |
| | | | | | |
Restricted cash and cash equivalents and investments | | 67,211 | | | 152,663 | | | 219,874 | |
Funds withheld receivable | | 15,534 | | | 128,451 | | | 143,985 | |
Other assets | | 685 | | | — | | | 685 | |
Total assets - reportable segments | | 93,191 | | | 990,358 | | | 1,083,549 | |
Corporate assets | | — | | | — | | | 435,385 | |
| | | | | | |
Total Assets | | $ | 93,191 | | | $ | 990,358 | | | $ | 1,518,934 | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information (continued)
The following tables set forth financial information relating to net premiums written by major line of business and reportable segment for the three and nine months ended September 30, 2024 and 2023:
| | | | | | | | | | | | | | | | | | |
For the Three Months Ended September 30, | | 2024 | | 2023 |
Net premiums written | | Total | | | | Total | | |
Diversified Reinsurance | | | | | | | | |
| | | | | | | | |
International | | $ | 9,035 | | | | | $ | 6,727 | | | |
| | | | | | | | |
| | | | | | | | |
Total Diversified Reinsurance | | 9,035 | | | | | 6,727 | | | |
AmTrust Reinsurance | | | | | | | | |
Small Commercial Business | | (73) | | | | | (160) | | | |
Specialty Program | | 14 | | | | | — | | | |
Specialty Risk and Extended Warranty | | (133) | | | | | 2,058 | | | |
Total AmTrust Reinsurance | | (192) | | | | | 1,898 | | | |
| | | | | | | | |
Total Net Premiums Written | | $ | 8,843 | | | | | $ | 8,625 | | | |
| | | | | | | | |
For the Nine Months Ended September 30, | | 2024 | | 2023 |
Net premiums written | | Total | | | Total | | |
Diversified Reinsurance | | | | | | | | |
| | | | | | | | |
International | | $ | 26,237 | | | | | $ | 20,152 | | | |
| | | | | | | | |
| | | | | | | | |
Total Diversified Reinsurance | | 26,237 | | | | | 20,152 | | | |
AmTrust Reinsurance | | | | | | | | |
Small Commercial Business | | (620) | | | | | (318) | | | |
Specialty Program | | (31) | | | | | 157 | | | |
Specialty Risk and Extended Warranty | | (90) | | | | | (3,731) | | | |
Total AmTrust Reinsurance | | (741) | | | | | (3,892) | | | |
| | | | | | | | |
Total Net Premiums Written | | $ | 25,496 | | | | | $ | 16,260 | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
3. Segment Information (continued)
The following tables set forth financial information for net premiums earned by major line of business and reportable segment for the three and nine months ended September 30, 2024 and 2023:
| | | | | | | | | | | | | | | | | | |
For the Three Months Ended September 30, | | 2024 | | 2023 |
Net premiums earned | | Total | | | Total | | |
Diversified Reinsurance | | | | | | | | |
| | | | | | | | |
International | | $ | 9,576 | | | | | $ | 7,207 | | | |
| | | | | | | | |
| | | | | | | | |
Total Diversified Reinsurance | | 9,576 | | | | | 7,207 | | | |
AmTrust Reinsurance | | | | | | | | |
Small Commercial Business | | (73) | | | | | (160) | | | |
Specialty Program | | 14 | | | | | — | | | |
Specialty Risk and Extended Warranty | | 3,886 | | | | | 5,432 | | | |
Total AmTrust Reinsurance | | 3,827 | | | | | 5,272 | | | |
| | | | | | | | |
Total Net Premiums Earned | | $ | 13,403 | | | | | $ | 12,479 | | | |
| | | | | | | | |
For the Nine Months Ended September 30, | | 2024 | | 2023 |
Net premiums earned | | Total | | | Total | | |
Diversified Reinsurance | | | | | | | | |
| | | | | | | | |
International | | $ | 26,796 | | | | | $ | 21,882 | | | |
| | | | | | | | |
| | | | | | | | |
Total Diversified Reinsurance | | 26,796 | | | | | 21,882 | | | |
AmTrust Reinsurance | | | | | | | | |
Small Commercial Business | | (620) | | | | | (318) | | | |
Specialty Program | | (31) | | | | | 157 | | | |
Specialty Risk and Extended Warranty | | 11,743 | | | | | 10,799 | | | |
Total AmTrust Reinsurance | | 11,092 | | | | | 10,638 | | | |
| | | | | | | | |
Total Net Premiums Earned | | $ | 37,888 | | | | | $ | 32,520 | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
4. Investments
The Company holds: (i) available-for-sale ("AFS") portfolios of fixed maturity and equity securities, carried at fair value; (ii) other investments, of which certain investments are carried at fair value and investments in direct lending entities are carried at cost less impairment; (iii) equity method investments; and (iv) funds held - directly managed.
a)Fixed Maturities
The amortized cost, gross unrealized gains and losses, and fair value of fixed maturities at September 30, 2024 and December 31, 2023 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
September 30, 2024 | | Original or amortized cost | | Gross unrealized gains | | Gross unrealized losses | | Fair value |
U.S. treasury bonds | | $ | 48,676 | | | $ | 17 | | | $ | — | | | $ | 48,693 | |
U.S. agency bonds – mortgage-backed | | 27,493 | | | — | | | (2,535) | | | 24,958 | |
| | | | | | | | |
Non-U.S. government bonds | | 48,997 | | | 37 | | | (292) | | | 48,742 | |
Collateralized loan obligations | | 65,973 | | | 4 | | | (140) | | | 65,837 | |
Corporate bonds | | 38,620 | | | — | | | (1,094) | | | 37,526 | |
| | | | | | | | |
| | | | | | | | |
Total fixed maturity investments | | $ | 229,759 | | | $ | 58 | | | $ | (4,061) | | | $ | 225,756 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, 2023 | | Original or amortized cost | | Gross unrealized gains | | Gross unrealized losses | | Fair value |
U.S. treasury bonds | | $ | 55,046 | | | $ | 8 | | | $ | (2) | | | $ | 55,052 | |
U.S. agency bonds – mortgage-backed | | 29,918 | | | — | | | (3,267) | | | 26,651 | |
| | | | | | | | |
Non-U.S. government bonds | | 21,219 | | | — | | | (468) | | | 20,751 | |
Collateralized loan obligations | | 80,591 | | | — | | | (1,788) | | | 78,803 | |
Corporate bonds | | 71,762 | | | — | | | (2,418) | | | 69,344 | |
| | | | | | | | |
| | | | | | | | |
Total fixed maturity investments | | $ | 258,536 | | | $ | 8 | | | $ | (7,943) | | | $ | 250,601 | |
The Company separately presents the accrued interest receivable balance on its AFS fixed maturity investments on the Condensed Consolidated Balance Sheets under accrued investment income. The amount of accrued interest receivable on AFS securities was $1,645 at September 30, 2024 (December 31, 2023: $1,418). The Company has elected the practical expedient to exclude accrued interest from both the fair value and the amortized cost basis of the AFS fixed maturity securities for the purposes of identifying and measuring any impairments under the allowance for expected credit losses standard adopted on January 1, 2023. Write-offs of accrued interest receivable balances are recognized in net investment gains and losses in the period in which they are deemed uncollectible. There was no write-off recognized on the accrued interest receivable during the nine months ended September 30, 2024 and 2023.
The contractual maturities of our fixed maturities are shown below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
| | | | | | | | | | | | | | | | | | |
| | | | |
September 30, 2024 | | Amortized cost | | Fair value | | | | |
Due in one year or less | | $ | 112,360 | | | $ | 112,257 | | | | | |
Due after one year through five years | | 23,374 | | | 22,234 | | | | | |
Due after five years through ten years | | 559 | | | 470 | | | | | |
| | | | | | | | |
| | 136,293 | | | 134,961 | | | | | |
U.S. agency bonds – mortgage-backed | | 27,493 | | | 24,958 | | | | | |
| | | | | | | | |
Collateralized loan obligations | | 65,973 | | | 65,837 | | | | | |
Total fixed maturity investments | | $ | 229,759 | | | $ | 225,756 | | | | | |
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
4. Investments (continued)
The following tables summarize fixed maturities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Less than 12 Months | | 12 Months or More | | Total |
September 30, 2024 | | Fair value | | Unrealized losses | | Fair value | | Unrealized losses | | Fair value | | Unrealized losses |
U.S. treasury bonds | | $ | — | | | $ | — | | | $ | 520 | | | $ | — | | | $ | 520 | | | $ | — | |
U.S. agency bonds – mortgage-backed | | — | | | — | | | 24,958 | | | (2,535) | | | 24,958 | | | (2,535) | |
| | | | | | | | | | | | |
Non-U.S. government bonds | | 20,746 | | | (10) | | | 3,033 | | | (282) | | | 23,779 | | | (292) | |
Collateralized loan obligations | | — | | | — | | | 61,490 | | | (140) | | | 61,490 | | | (140) | |
Corporate bonds | | — | | | — | | | 37,526 | | | (1,094) | | | 37,526 | | | (1,094) | |
| | | | | | | | | | | | |
Total temporarily impaired fixed maturities | | $ | 20,746 | | | $ | (10) | | | $ | 127,527 | | | $ | (4,051) | | | $ | 148,273 | | | $ | (4,061) | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
At September 30, 2024, there were 46 securities in an unrealized loss position with a fair value of $148,273 and unrealized losses of $4,061. Of these securities in an unrealized loss position, there were 44 securities in our portfolio that have been in an unrealized loss position for twelve months or greater with a fair value of $127,527 and unrealized losses of $4,051.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Less than 12 Months | | 12 Months or More | | Total |
December 31, 2023 | | Fair value | | Unrealized losses | | Fair value | | Unrealized losses | | Fair value | | Unrealized losses |
U.S. treasury bonds | | $ | 518 | | | $ | (2) | | | $ | — | | | $ | — | | | $ | 518 | | | $ | (2) | |
U.S. agency bonds – mortgage-backed | | — | | | — | | | 26,651 | | | (3,267) | | | 26,651 | | | (3,267) | |
| | | | | | | | | | | | |
Non-U.S. government bonds | | 8,217 | | | (1) | | | 10,343 | | | (467) | | | 18,560 | | | (468) | |
Collateralized loan obligations | | — | | | — | | | 78,803 | | | (1,788) | | | 78,803 | | | (1,788) | |
Corporate bonds | | — | | | — | | | 69,344 | | | (2,418) | | | 69,344 | | | (2,418) | |
| | | | | | | | | | | | |
Total temporarily impaired fixed maturities | | $ | 8,735 | | | $ | (3) | | | $ | 185,141 | | | $ | (7,940) | | | $ | 193,876 | | | $ | (7,943) | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
At December 31, 2023, there were 59 securities in an unrealized loss position with a fair value of $193,876 and unrealized losses of $7,943. Of these securities in an unrealized loss position, there were 56 securities in our portfolio that have been in an unrealized loss position for twelve months or greater with a fair value of $185,141 and unrealized losses of $7,940.
Allowance for Expected Credit Losses & Non-Credit Related Impairment Costs
The Company evaluates AFS securities for impairment when fair value is below amortized cost on a quarterly basis. If the Company intends to sell or will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss) and included in net investment gains (losses). If the Company does not intend to sell or will not be required to sell the security before its anticipated recovery, an allowance for expected credit losses is established and the portion of the loss relating to credit factors is recorded in net income (loss). The non-credit impairment amount of the loss (which could be related to interest rates and/or market conditions) is recognized in other comprehensive income.
To estimate the allowance for expected credit losses for most of the AFS securities, the Company analyzes projected cash flows which are primarily driven by assumptions regarding loss severity, probability of default and projected recovery rates. The Company's determination of default and loss severity rates are based on credit rating, credit analysis and macroeconomic forecasts. Unrealized losses on securities issued or backed, either explicitly or implicitly by the U.S. government are not analyzed for credit losses. The Company has concluded that any possibility of a credit loss on these securities is highly unlikely due to the explicit U.S. government guarantee related to certain securities (e.g., Government National Mortgage Association issuances) and the implicit guarantee related to other securities that has been validated by past actions (e.g., U.S. government bailout of Federal National Mortgage Association and Federal Home Loan Mortgage Corporation during the 2008 credit crisis). Although these securities are not analyzed for credit losses, they are evaluated for impairment based on the Company's intention to sell and likely requirement to sell.
Based on the Company's analysis at September 30, 2024 and 2023, respectively, the unrealized losses on the Company’s AFS fixed maturity securities were due to non-credit factors and were expected to be recovered as the related securities approach maturity. At September 30, 2024, the Company did not intend to sell the securities in an unrealized loss position and it is not more likely than not that the Company will be required to sell these securities before the anticipated recovery of their amortized costs. Therefore, there was no allowance recorded for expected credit losses on AFS securities for the three and nine months ended September 30, 2024 and 2023.
MAIDEN HOLDINGS, LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands of U.S. dollars, except share and per share data)
4. Investments (continued)
The following tables summarize the credit ratings of our fixed maturities as at September 30, 2024 and December 31, 2023:
| | | | | | | | | | | | | | | | | | | | |
September 30, 2024 | | Amortized cost | | Fair value | | % of Total fair value |
U.S. treasury bonds | | $ | 48,676 | | | $ | 48,693 | | | 21.5 | % |
U.S. agency bonds – mortgage-backed | | 27,493 | | | 24,958 | | | 11.1 | % |
AAA | | 76,613 | | | 76,474 | | | 33.9 | % |
AA+, AA, AA- | | 39,956 | | | 39,678 | | | 17.6 | % |
A+, A, A- | | 18,387 | | | 17,610 | | | 7.8 | % |
BBB+, BBB, BBB- | | 18,634 | | | 18,343 | | | 8.1 | % |
| | | | | | |
Total fixed maturities (1) | | $ | 229,759 | | | $ | 225,756 | | | 100.0 | % |
| | | | | | | | | | | | | | | | | | | | |
December 31, 2023 | | Amortized cost | | Fair value | | % of Total fair value |
U.S. treasury bonds | | $ | 55,046 | | | $ | 55,052 | | | 22.0 | % |
U.S. agency bonds – mortgage-backed | | 29,918 | | | 26,651 | | | 10.6 | % |
AAA | | 84,455 | | | 82,703 | | | 33.0 | % |
AA+, AA, AA- | | 18,952 | | | 18,372 | | | |